Mutant EGIII cellulase, DNA encoding such EGIII compositions and methods for obtaining same
US6635465B1 · kind B1 · utility
2Cited by
9References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 4, 2000 |
| Grant date | Oct 21, 2003 |
| Priority date | — |
| Expiry date | Sep 7, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y302/01004
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to variant EGIII cellulases that have improved stability and/or performance. The variant cellulases have replacements at sensitive residues to improve stability and/or performance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.